Researchers say an experimental Alzheimer's drug may calm brain inflammation linked to alcohol withdrawal, potentially reducing relapse and neural damage.
Scripps Research scientists have found that LY2444296 - a compound that selectively blocks the kappa opioid receptor (KOP) - may reduce drinking in cases of alcohol dependence in animal studies. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results